Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Cited In for PubMed (Select 16954474)

1.

Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.

Winkel RR, von Euler-Chelpin M, Nielsen M, Diao P, Nielsen MB, Uldall WY, Vejborg I.

BMC Cancer. 2015 Apr 12;15:274. doi: 10.1186/s12885-015-1256-3.

2.

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.

Keller BM, McCarthy AM, Chen J, Armstrong K, Conant EF, Domchek SM, Kontos D.

BMC Cancer. 2015 Mar 18;15:143. doi: 10.1186/s12885-015-1159-3.

3.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

PMID:
25713150
4.

Prospective approach to breast cancer risk prediction in African American women: the black women's health study model.

Boggs DA, Rosenberg L, Adams-Campbell LL, Palmer JR.

J Clin Oncol. 2015 Mar 20;33(9):1038-44. doi: 10.1200/JCO.2014.57.2750. Epub 2015 Jan 26.

PMID:
25624428
5.

Polyacrylamide gels for invadopodia and traction force assays on cancer cells.

Jerrell RJ, Parekh A.

J Vis Exp. 2015 Jan 4;(95):52343. doi: 10.3791/52343.

PMID:
25590238
6.

The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

McCarthy AM, Keller B, Kontos D, Boghossian L, McGuire E, Bristol M, Chen J, Domchek S, Armstrong K.

Breast Cancer Res. 2015 Jan 8;17(1):1. doi: 10.1186/s13058-014-0509-4.

7.

Emerging Concepts in Breast Cancer Risk Prediction.

Gierach GL, Yang XR, Figueroa JD, Sherman ME.

Curr Obstet Gynecol Rep. 2013 Mar;2(1):43-52.

8.

Risk determination and prevention of breast cancer.

Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, Gescher AJ, Key TJ, Saxton JM, Harvie MN.

Breast Cancer Res. 2014 Sep 28;16(5):446. doi: 10.1186/s13058-014-0446-2.

9.

Breast density measurements using ultrasound tomography for patients undergoing tamoxifen treatment.

Sak M, Duric N, Littrup P, Li C, Bey-Knight L, Sherman M, Boyd N, Gierach G.

Proc SPIE Int Soc Opt Eng. 2013 Mar 29;8675:86751E.

10.

Comparison of sound speed measurements on two different ultrasound tomography devices.

Sak M, Duric N, Littrup P, Bey-Knight L, Sherman M, Gierach G, Malyarenko A.

Proc SPIE Int Soc Opt Eng. 2014 Mar 20;9040:90400S.

11.

Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.

Warwick J, Birke H, Stone J, Warren RM, Pinney E, Brentnall AR, Duffy SW, Howell A, Cuzick J.

Breast Cancer Res. 2014 Oct 8;16(5):451. doi: 10.1186/s13058-014-0451-5.

12.

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.

Mayers JR, Wu C, Clish CB, Kraft P, Torrence ME, Fiske BP, Yuan C, Bao Y, Townsend MK, Tworoger SS, Davidson SM, Papagiannakopoulos T, Yang A, Dayton TL, Ogino S, Stampfer MJ, Giovannucci EL, Qian ZR, Rubinson DA, Ma J, Sesso HD, Gaziano JM, Cochrane BB, Liu S, Wactawski-Wende J, Manson JE, Pollak MN, Kimmelman AC, Souza A, Pierce K, Wang TJ, Gerszten RE, Fuchs CS, Vander Heiden MG, Wolpin BM.

Nat Med. 2014 Oct;20(10):1193-8. doi: 10.1038/nm.3686. Epub 2014 Sep 28.

13.

Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative.

Liu D, Zheng Y, Prentice RL, Hsu L.

J Am Stat Assoc. 2014 Jun 1;109(506):514-524.

PMID:
25018574
14.

Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.

Wang JL, Patten S, Sareen J, Bolton J, Schmitz N, MacQueen G.

Depress Anxiety. 2014 May;31(5):451-7.

15.

Mammographic breast density as a risk factor for breast cancer: awareness in a recently screened clinical sample.

O'Neill SC, Leventhal KG, Scarles M, Evans CN, Makariou E, Pien E, Willey S.

Womens Health Issues. 2014 May-Jun;24(3):e321-6. doi: 10.1016/j.whi.2014.02.005. Epub 2014 Apr 13.

16.

Clinical prediction rules in practice: review of clinical guidelines and survey of GPs.

Plüddemann A, Wallace E, Bankhead C, Keogh C, Van der Windt D, Lasserson D, Galvin R, Moschetti I, Kearley K, O'Brien K, Sanders S, Mallett S, Malanda U, Thompson M, Fahey T, Stevens R.

Br J Gen Pract. 2014 Apr;64(621):e233-42. doi: 10.3399/bjgp14X677860.

17.

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women.

Vogel VG.

Breast Cancer (Dove Med Press). 2011 Oct 20;3:127-37. doi: 10.2147/BCTT.S11288. Review.

18.

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain.

Arrospide A, Forné C, Rué M, Torà N, Mar J, Baré M.

BMC Cancer. 2013 Dec 10;13:587. doi: 10.1186/1471-2407-13-587.

19.

Beyond breast cancer: mammographic features and mortality risk in a population of healthy women.

Murphy RA, Schairer C, Gierach GL, Byrne C, Sherman ME, Register TC, Ding J, Kritchevsky SB, Harris TB.

PLoS One. 2013 Oct 25;8(10):e78722. doi: 10.1371/journal.pone.0078722. eCollection 2013.

20.

Korean risk assessment model for breast cancer risk prediction.

Park B, Ma SH, Shin A, Chang MC, Choi JY, Kim S, Han W, Noh DY, Ahn SH, Kang D, Yoo KY, Park SK.

PLoS One. 2013 Oct 25;8(10):e76736. doi: 10.1371/journal.pone.0076736. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk